AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial.

Autor: Ivashchenko AA; ChemRar High-Tech Center, Khimki, Moscow region, Russian Federation., Dmitriev KA; Russian Direct Investment Fund, Moscow, Russian Federation., Vostokova NV; IPHARMA LLC, Skolkovo Innovative Centre, Moscow, Russian Federation., Azarova VN; IPHARMA LLC, Skolkovo Innovative Centre, Moscow, Russian Federation., Blinow AA; Chromis LLC, Skolkovo Innovative Centre, Moscow, Russian Federation., Egorova AN; IPHARMA LLC, Skolkovo Innovative Centre, Moscow, Russian Federation., Gordeev IG; City Clinical Hospital n.a. O.M. Filatov, Moscow, Russian Federation., Ilin AP; Department of Chemistry and Technology, Chemical Diversity Research Institute, Khimki, Moscow region, Russian Federation., Karapetian RN; Department of Biology, Chemical Diversity Research Institute, Khimki, Moscow region, Russian Federation., Kravchenko DV; Department of Chemistry and Technology, Chemical Diversity Research Institute, Khimki, Moscow region, Russian Federation., Lomakin NV; Central Clinical Hospital with Polyclinic, Moscow, Russian Federation., Merkulova EA; IPHARMA LLC, Skolkovo Innovative Centre, Moscow, Russian Federation., Papazova NA; Department of Finished Dosage Forms, Chemical Diversity Research Institute, Khimki, Moscow region, Russian Federation., Pavlikova EP; Moscow State University n.a. M. V. Lomonosov, Moscow, Russian Federation., Savchuk NP; Chemical Diversity Research Institute, Khimki, Moscow region, Russian Federation., Simakina EN; Clinical Hospital No.1, Smolensk, Russian Federation., Sitdekov TA; Russian Direct Investment Fund, Moscow, Russian Federation., Smolyarchuk EA; First Moscow State Medical University n.a. I.M. Sechenov, Moscow, Russian Federation., Tikhomolova EG; Infectious clinical hospital No. 2, Nizhny Novgorod, Russian Federation., Yakubova EV; Chromis LLC, Skolkovo Innovative Centre, Moscow, Russian Federation., Ivachtchenko AV; Chemical Diversity Research Institute, Khimki, Moscow region, Russian Federation.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Aug 02; Vol. 73 (3), pp. 531-534.

[Determination of biological activity of hydrogel preparations based on ketoconazole and clotrimazole].

Autor: Papazova NA, Gorbunova NA, Abramovich RA

Publikováno v: Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] [Antibiot Khimioter] 2004; Vol. 49 (2), pp. 8-10.